Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin and Combined User
This webinar enables physicians to improve their knowledge and patient practices with respect to treatment recommendations for opioid analgesic (OA), heroin, and combined users through opioid replacement therapy (ORT). The webinar will present findings from the "Starting Treatment With Agonist Replacement Therapies (START)" study. Physicians will learn about the differences in both methadone and buprenorphine treatment outcomes for heroin versus OA users and injectors versus non-injectors.
ASAM and/or CSAM Members: Free
You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
Presenter: Jennifer Sharpe Potter, Ph.D., M.P.H.
Associate Professor in the Departments of Psychiatry and Anesthesiology and Assistant Dean for Research and Student Programs in the School of Medicine at the University of Texas Health Science Center San Antonio.
Disclosure: None of the faculty or planners of this activity disclosed any commercial interests.
- 1.00 AMA Category 1
Upon completion of this webinar, participants should be able to:
- Explain to patients differences in opioid replacement treatment (ORT) options.
- Explain to patients differences in potential treatment outcomes between heroin and OA users and between injectors and non-injectors.
- Summarize the importance of competently counseling patients about ORT options, based on patients’ type and route of opioid use.